Clear Harbor Asset Management LLC continued to hold its position in shares of Stryker Corporation (NYSE:SYK) during the second quarter, Holdings Channel reports. The fund owned 2,389 shares of the medical technology company’s stock at the end of the second quarter. Clear Harbor Asset Management LLC’s holdings in Stryker Corporation were worth $345,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Bank of Montreal Can raised its position in shares of Stryker Corporation by 0.6% in the first quarter. Bank of Montreal Can now owns 193,426 shares of the medical technology company’s stock valued at $25,466,000 after buying an additional 1,130 shares in the last quarter. Private Trust Co. NA raised its position in shares of Stryker Corporation by 18.8% in the first quarter. Private Trust Co. NA now owns 23,088 shares of the medical technology company’s stock valued at $3,039,000 after buying an additional 3,660 shares in the last quarter. Prospera Financial Services Inc purchased a new position in shares of Stryker Corporation during the first quarter valued at about $200,000. BKD Wealth Advisors LLC raised its position in shares of Stryker Corporation by 1.1% in the first quarter. BKD Wealth Advisors LLC now owns 3,356 shares of the medical technology company’s stock valued at $442,000 after buying an additional 35 shares in the last quarter. Finally, Atria Investments LLC raised its position in shares of Stryker Corporation by 4.7% in the first quarter. Atria Investments LLC now owns 6,211 shares of the medical technology company’s stock valued at $818,000 after buying an additional 280 shares in the last quarter. 73.79% of the stock is owned by hedge funds and other institutional investors.

Stryker Corporation (NYSE:SYK) traded down 0.12% during trading on Wednesday, hitting $147.26. The stock had a trading volume of 343,995 shares. The company’s 50 day moving average is $144.07 and its 200 day moving average is $136.07. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $148.84. The firm has a market cap of $55.08 billion, a PE ratio of 32.87 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The firm’s revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.39 EPS. Equities research analysts forecast that Stryker Corporation will post $6.50 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be paid a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s payout ratio is currently 37.95%.

ILLEGAL ACTIVITY WARNING: “Clear Harbor Asset Management LLC Continues to Hold Stake in Stryker Corporation (SYK)” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/clear-harbor-asset-management-llc-continues-to-hold-stake-in-stryker-corporation-syk/1496104.html.

Several research analysts have recently issued reports on SYK shares. Needham & Company LLC reissued a “sell” rating on shares of Stryker Corporation in a research report on Wednesday, April 26th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $140.00 price objective (up previously from $135.00) on shares of Stryker Corporation in a research report on Wednesday, April 26th. Cowen and Company set a $150.00 price objective on Stryker Corporation and gave the company an “outperform” rating in a research report on Wednesday, April 26th. Barclays PLC reaffirmed a “sell” rating and set a $133.00 price objective on shares of Stryker Corporation in a research report on Thursday, April 27th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and set a $148.00 price objective (up previously from $135.00) on shares of Stryker Corporation in a research report on Saturday, April 29th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have given a buy rating to the company. Stryker Corporation currently has an average rating of “Hold” and an average target price of $144.03.

In other news, insider David Floyd sold 19,305 shares of the stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $144.56, for a total transaction of $2,790,730.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Graham A. Mclean sold 1,124 shares of the stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total transaction of $164,396.24. Following the sale, the insider now directly owns 8,983 shares in the company, valued at $1,313,853.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,810 shares of company stock worth $4,754,958. Corporate insiders own 7.40% of the company’s stock.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.